235.97USD+1.00%Mkt Cap: 12.14B USDP/E: —Last update: 2026-05-22
Axsome Therapeutics, Inc., a biopharmaceutical company, develops and delivers novel therapies for the management of central nervous system (CNS) disorders in the United States. The company's commercial product portfolio …
Industry Peers
Biotechnologyloading…
Indicators:|
Key Statistics
Company
Market Cap12.14B USD
Enterprise Value11.94B USD
Revenue (TTM)708.24M USD
Gross Profit591.02M USD
Net Income (TTM)-183.17M USD
Revenue/Share14.07 USD
Last Price235.97 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees1.2K
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS05464T1043
Valuation
P/E (Trailing)—
P/E (Forward)39.69
PEG—
EV/EBITDA-71.38
EV/Revenue16.86
P/S16.98
P/B220.00
EPS (TTM)-3.71
EPS (Forward)5.89
52W Range
96.0999% of range236.84
52W High236.84 USD
52W Low96.09 USD
Profitability
Gross Margin92.56%
Oper. Margin-32.83%
EBITDA Margin-23.61%
Profit Margin-28.69%
ROE-207.46%
ROA-26.55%
Growth
Revenue Growth57.40%
Earnings Growth—
Cash Flow & Leverage
Operating CF-93.41M USD
CapEx (TTM)480.00K USD
FCF Margin-0.54%
FCF Yield-0.03%
Net Debt-85.21M USD
Net Debt/EBITDA0.51
Balance Sheet
Debt/Equity2.47
Current Ratio1.39
Quick Ratio1.27
Book Value/Sh1.062 USD
Cash/Share5.929 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.2 (Strong Buy)
Target (Mean)270.28 USD
Target Range200.00 USD – 328.81 USD
# Analysts21
Ownership
Shares Out.51.46M
Float43.55M
Insiders15.38%
Institutions76.86%
Short Interest
Short Ratio3.9d
Short % Float8.36%
Short % Out.5.34%
Shares Short2.75M
Short (prev mo.)2.83M
Technical
SMA 50188.36 (+25.3%)
SMA 200156.04 (+51.2%)
Beta0.58
S&P 52W Chg28.31%
Avg Vol (30d)814.89K
Avg Vol (10d)609.52K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—